Vellenga E - Search Results

1

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG. Plasschaert SL, et al. Among authors: vellenga e. Clin Cancer Res. 2003 Nov 1;9(14):5171-7. Clin Cancer Res. 2003. PMID: 14613996

2

Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.

van der Weide K, de Jonge-Peeters SD, Kuipers F, de Vries EG, Vellenga E. van der Weide K, et al. Among authors: vellenga e. Clin Cancer Res. 2009 May 1;15(9):3076-83. doi: 10.1158/1078-0432.CCR-08-3004. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383813 Free article.

3

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

van der Kolk DM, Vellenga E, Scheffer GL, Müller M, Bates SE, Scheper RJ, de Vries EG. van der Kolk DM, et al. Among authors: vellenga e. Blood. 2002 May 15;99(10):3763-70. doi: 10.1182/blood.v99.10.3763. Blood. 2002. PMID: 11986234 Free article.

4

The role of drug efflux pumps in acute myeloid leukemia.

van der Kolk DM, de Vries EG, Müller M, Vellenga E. van der Kolk DM, et al. Among authors: vellenga e. Leuk Lymphoma. 2002 Apr;43(4):685-701. doi: 10.1080/10428190290016773. Leuk Lymphoma. 2002. PMID: 12153153 Review.

5

High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.

Plasschaert SL, Vellenga E, de Bont ES, van der Kolk DM, Veerman AJ, Sluiter WJ, Daenen SM, de Vries EG, Kamps WA. Plasschaert SL, et al. Among authors: vellenga e. Leuk Lymphoma. 2003 Jan;44(1):85-95. doi: 10.1080/1042819021000040288. Leuk Lymphoma. 2003. PMID: 12691146

6

Breast cancer resistance protein (BCRP) in acute leukemia.

Plasschaert SL, Van Der Kolk DM, De Bont ES, Vellenga E, Kamps WA, De Vries EG. Plasschaert SL, et al. Among authors: vellenga e. Leuk Lymphoma. 2004 Apr;45(4):649-54. doi: 10.1080/10428190310001597928. Leuk Lymphoma. 2004. PMID: 15160935 Review.

7

Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.

Plasschaert SL, de Bont ES, Boezen M, vander Kolk DM, Daenen SM, Faber KN, Kamps WA, de Vries EG, Vellenga E. Plasschaert SL, et al. Among authors: vellenga e. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8661-8. doi: 10.1158/1078-0432.CCR-05-1096. Clin Cancer Res. 2005. PMID: 16361551

8

Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells.

Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG, Vellenga E. Peeters SD, et al. Among authors: vellenga e. Exp Hematol. 2006 May;34(5):622-30. doi: 10.1016/j.exphem.2006.01.020. Exp Hematol. 2006. PMID: 16647568 Free article.

9

ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance.

de Jonge-Peeters SD, Kuipers F, de Vries EG, Vellenga E. de Jonge-Peeters SD, et al. Among authors: vellenga e. Crit Rev Oncol Hematol. 2007 Jun;62(3):214-26. doi: 10.1016/j.critrevonc.2007.02.003. Epub 2007 Mar 23. Crit Rev Oncol Hematol. 2007. PMID: 17368038 Review.

10

Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

Plasschaert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES. Plasschaert SL, et al. Among authors: vellenga e. Cancer Treat Rev. 2004 Feb;30(1):37-51. doi: 10.1016/S0305-7372(03)00140-3. Cancer Treat Rev. 2004. PMID: 14766125 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters